Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4954)
All Articles published online
|
Jul 27, 2012 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sun WH, Song MQ, Jiang CQ, Xin YN, Ma JL, Liu YX, Ma L, Lin ZH, Li CY, Liu L, Zhang M, Chu LL, Jiang XJ, Wan Q, Zhou L, Ren R, Meng LF. Lifestyle intervention in non-alcoholic fatty liver disease in Chengyang District, Qingdao, China. World J Hepatol 2012; 4(7): 224-230 [PMID: 22855698 DOI: 10.4254/wjh.v4.i7.224] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v4/i7/224.htm |
| Number | Citing Articles |
| 1 |
Dimitrios A. Koutoukidis, Nerys M. Astbury, Kate E. Tudor, Elizabeth Morris, John A. Henry, Michaela Noreik, Susan A. Jebb, Paul Aveyard. Association of Weight Loss Interventions With Changes in Biomarkers of Nonalcoholic Fatty Liver Disease. JAMA Internal Medicine 2019; 179(9): 1262 doi: 10.1001/jamainternmed.2019.2248
|
| 2 |
Mika Aizawa, Seiichi Inagaki, Michiko Moriyama, Kenichiro Asano, Masayuki Kakehashi, Ying-Mei Feng. Modeling the natural history of fatty liver using lifestyle–related risk factors: Effects of body mass index (BMI) on the life–course of fatty liver. PLOS ONE 2019; 14(10): e0223683 doi: 10.1371/journal.pone.0223683
|
| 3 |
Dirk J. van der Windt, Vikas Sud, Hongji Zhang, Allan Tsung, Hai Huang. The Effects of Physical Exercise on Fatty Liver Disease. Gene Expression 2018; 18(2): 89 doi: 10.3727/105221617X15124844266408
|
| 4 |
Lucia Brodosi, Salvatore Petta, Maria L. Petroni, Giulio Marchesini, Maria C. Morelli. Management of Diabetes in Candidates for Liver Transplantation and in Transplant Recipients. Transplantation 2022; 106(3): 462 doi: 10.1097/TP.0000000000003867
|
| 5 |
Tiziana Fernández, Macarena Viñuela, Catalina Vidal, Francisco Barrera, Pavel Strnad. Lifestyle changes in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis. PLOS ONE 2022; 17(2): e0263931 doi: 10.1371/journal.pone.0263931
|
| 6 |
Tonya Paris, Elena S. George, Stuart K. Roberts, Audrey C. Tierney. The effects of diet and lifestyle interventions on insulin resistance in patients with nonalcoholic fatty liver disease: a systematic review. European Journal of Gastroenterology & Hepatology 2017; 29(8): 867 doi: 10.1097/MEG.0000000000000890
|
| 7 |
Anas Hashem, Amani Khalouf, Andres Acosta. Management of Obesity and Nonalcoholic Fatty Liver Disease: A Literature Review. Seminars in Liver Disease 2021; 41(04): 435 doi: 10.1055/s-0041-1731704
|
| 8 |
Diego García-Compeán, Ramesh Kumar, Ángel Noe del Cueto-Aguilera, Héctor Jesús Maldonado-Garza, Jesús Zacarías Villarreal-Pérez. Body weight loss and glycemic control on the outcomes of patients with NAFLD. The role of new antidiabetic agents. Annals of Hepatology 2023; 28(4): 100751 doi: 10.1016/j.aohep.2022.100751
|
| 9 |
Kate Hallsworth, Leon A. Adams. Lifestyle modification in NAFLD/NASH: Facts and figures. JHEP Reports 2019; 1(6): 468 doi: 10.1016/j.jhepr.2019.10.008
|
| 10 |
Newaz Hossain, Pushpjeet Kanwar, Smruti R. Mohanty. A Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLD. Gastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/7109270
|
| 11 |
Manuel Romero-Gómez, Shira Zelber-Sagi, Michael Trenell. Treatment of NAFLD with diet, physical activity and exercise. Journal of Hepatology 2017; 67(4): 829 doi: 10.1016/j.jhep.2017.05.016
|
| 12 |
Gholam Rasul Mohammad Rahimi, Seyyed Reza Attarzadeh Hosseini. Effect of Aerobic Exercise Alone or in Conjunction With Diet on Liver Function, Insulin Resistance and Lipids in Non-Alcoholic Fatty Liver Disease. Biological Research For Nursing 2022; 24(2): 259 doi: 10.1177/10998004211068026
|
| 13 |
Yukihiro Bando, Ayumi Ogawa, Kazuhide Ishikura, Hideo Kanehara, Azusa Hisada, Kazuo Notumata, Kazuhiro Okafuji, Daisyu Toya. The effects of ipragliflozin on the liver-to-spleen attenuation ratio as assessed by computed tomography and on alanine transaminase levels in Japanese patients with type 2 diabetes mellitus. Diabetology International 2017; 8(2): 218 doi: 10.1007/s13340-016-0302-y
|
| 14 |
Giulio Marchesini, Salvatore Petta, Riccardo Dalle Grave. Diet, weight loss, and liver health in nonalcoholic fatty liver disease: Pathophysiology, evidence, and practice. Hepatology 2016; 63(6): 2032 doi: 10.1002/hep.28392
|
| 15 |
Alia Hadefi, Marianna Arvanitakis, Eric Trépo, Shira Zelber‐Sagi. Dietary strategies in non‐alcoholic fatty liver disease patients: From evidence to daily clinical practice, a systematic review. United European Gastroenterology Journal 2023; 11(7): 663 doi: 10.1002/ueg2.12443
|
| 16 |
Pushpjeet Kanwar, Kris V. Kowdley. The Metabolic Syndrome and Its Influence on Nonalcoholic Steatohepatitis. Clinics in Liver Disease 2016; 20(2): 225 doi: 10.1016/j.cld.2015.10.002
|
| 17 |
Maureen Whitsett, Lisa B VanWagner. Physical activity as a treatment of non-alcoholic fatty liver disease: A systematic review. World Journal of Hepatology 2015; 7(16): 2041-2052 doi: 10.4254/wjh.v7.i16.2041
|
| 18 |
Siôn A. Parry, Leanne Hodson. Managing NAFLD in Type 2 Diabetes: The Effect of Lifestyle Interventions, a Narrative Review. Advances in Therapy 2020; 37(4): 1381 doi: 10.1007/s12325-020-01281-6
|
| 19 |
Elena Buzzetti, Audrey Linden, Lawrence MJ Best, Angela M Madden, Danielle Roberts, Thomas J G Chase, Suzanne C Freeman, Nicola J Cooper, Alex J Sutton, Dominic Fritche, Elisabeth Jane Milne, Kathy Wright, Chavdar S Pavlov, Brian R Davidson, Emmanuel Tsochatzis, Kurinchi Selvan Gurusamy. Lifestyle modifications for nonalcohol-related fatty liver disease: a network meta-analysis. Cochrane Database of Systematic Reviews 2021; 2021(6) doi: 10.1002/14651858.CD013156.pub2
|
| 20 |
G. Targher, G. Marchesini, C.D. Byrne. Risk of type 2 diabetes in patients with non-alcoholic fatty liver disease: Causal association or epiphenomenon?. Diabetes & Metabolism 2016; 42(3): 142 doi: 10.1016/j.diabet.2016.04.002
|
| 21 |
Maria Letizia Petroni, Lucia Brodosi, Elisabetta Bugianesi, Giulio Marchesini. Management of non-alcoholic fatty liver disease. BMJ 2021; : m4747 doi: 10.1136/bmj.m4747
|
| 22 |
Anil C. Anand, Subrata K. Acharya. Nonalcoholic Steatohepatitis, Peroxisome Proliferator–Activated Receptors and Our Good Glitazar: Proof of the Pudding is in the Eating. Journal of Clinical and Experimental Hepatology 2022; 12(2): 263 doi: 10.1016/j.jceh.2022.01.008
|
| 23 |
Christina N Katsagoni, Michael Georgoulis, George V Papatheodoridis, Demosthenes B Panagiotakos, Meropi D Kontogianni. Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: A meta-analysis. Metabolism 2017; 68: 119 doi: 10.1016/j.metabol.2016.12.006
|